Colonoscopy Bowel Preparation Drugs Market Is Expanding Rapidly With Sebela Pharmaceuticals Receiving The U.S. FDA Approval For SUTAB Tablets, Indicated For Colonoscopy Penetration
Colonoscopy is a process where a doctor inserts a flexible tube into the anus to view the colon or rectum. The colon is then prepared for examination using a camera designed to see the inner lining of the colon. If there are any abnormalities in the inner lining this can be detected and avoided. Colonoscopy bowel preparation drugs are typically used for the treatment of colorectal cancer. As per the American Society of Clinical Oncology (ASCO), colorectal cancer is the third most common cancer diagnosed in both men and women in the U.S. According to the same source, around 147,950 adults in the U.S. were diagnosed with colorectal cancer, of which 104,610 new cases of colon cancer and 43,340 new cases of rectal cancer. As a result of this, the demand for adequate medications, therapeutics, and treatment options has increased significantly in the recent past. Thus, such factors can stimulate growth of the colonoscopy bowel penetration drugs market.
When it comes to regional impact, developed countries such as
the U.S. are showing promising signs in the colonoscopy bowel penetration drugs
market. This is due to the fact that there is a high prevalence of colorectal
cancer. Besides, another developed region such as Europe is gaining significant
traction in the colonoscopy bowel penetration drugs market. This is due to the
fact that key players are collaborating to enhance their global footprint.
Recently, in November 2020, Sebela Pharmaceuticals received
the U.S. Food and Drug Administration (FDA) approval for its SUTAB tablets,
indicated for colonoscopy penetration.
However, there are various adverse effects associated with
cancer drugs, which could limit the adoption of colonoscopy bowel penetration
drugs. Besides, these drugs are significantly expensive, which tends to inhibit
growth of the colonoscopy bowel penetration drugs market.
A common misconception that people have is that they have to
be constipated in order to have their colonoscopy. This is not true. In fact,
many of the most common conditions can be found in the large intestine and not
the colon. Constipation is a common symptom to signify a problem somewhere else
in the digestive tract. Therefore, colonoscopy should not be used as a primary
method to detect problems in the colon. Colonoscopy is a necessary procedure
that many individuals are happy they have undergone. While it is important to
fully understand the colonoscopy process and the importance of proper bowel
preparation, it does not have to be a painful or traumatic experience. There
are lots of ongoing research and development activities in the pharmaceutical
industry for the discovery of effective colonoscopy bowel penetration drugs.
Such activities can augment growth of the colonoscopy bowel penetration drugs
market.
Comments
Post a Comment